Principal Financial Group Inc Adma Biologics, Inc. Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q4 2024

A detailed history of Principal Financial Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 1,259,014 shares of ADMA stock, worth $24.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,259,014
Holding current value
$24.7 Million
% of portfolio
0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
BUY
$15.62 - $22.62 $19.7 Million - $28.5 Million
1,259,014 New
1,259,014 $21.6 Million
Q3 2024

Oct 31, 2024
BUY
$11.21 - $20.03 $11.9 Million - $21.2 Million
1,059,394 Added 785.74%
1,194,221 $23.9 Million
Q2 2024

Jul 29, 2024
SELL
$5.98 - $11.18 $8,569 - $16,020
-1,433 Reduced 1.05%
134,827 $1.51 Million
Q1 2024

Apr 29, 2024
SELL
$4.4 - $6.74 $98,445 - $150,800
-22,374 Reduced 14.1%
136,260 $899,000
Q4 2023

Feb 07, 2024
BUY
$3.08 - $4.52 $73,439 - $107,774
23,844 Added 17.69%
158,634 $717,000
Q3 2023

Nov 02, 2023
BUY
$3.47 - $4.61 $104,405 - $138,705
30,088 Added 28.74%
134,790 $482,000
Q2 2023

Aug 07, 2023
BUY
$3.12 - $4.22 $6,942 - $9,389
2,225 Added 2.17%
104,702 $386,000
Q1 2023

May 09, 2023
SELL
$3.01 - $3.87 $20,085 - $25,824
-6,673 Reduced 6.11%
102,477 $339,000
Q4 2022

Feb 09, 2023
BUY
$2.47 - $3.88 $72,524 - $113,924
29,362 Added 36.8%
109,150 $423,000
Q3 2022

Nov 09, 2022
SELL
$2.03 - $2.86 $110,809 - $156,115
-54,586 Reduced 40.62%
79,788 $194,000
Q2 2022

Aug 10, 2022
BUY
$1.43 - $2.2 $170,646 - $262,532
119,333 Added 793.38%
134,374 $266,000
Q1 2022

May 09, 2022
SELL
$1.28 - $1.83 $1,084 - $1,550
-847 Reduced 5.33%
15,041 $28,000
Q4 2021

Feb 09, 2022
SELL
$1.09 - $1.66 $3,156 - $4,807
-2,896 Reduced 15.42%
15,888 $22,000
Q3 2021

Nov 09, 2021
SELL
$1.13 - $1.65 $3,438 - $5,020
-3,043 Reduced 13.94%
18,784 $21,000
Q2 2021

Aug 10, 2021
SELL
$1.51 - $2.07 $511,412 - $701,075
-338,684 Reduced 93.95%
21,827 $34,000
Q1 2021

May 10, 2021
BUY
$1.67 - $2.95 $41,671 - $73,611
24,953 Added 7.44%
360,511 $634,000
Q4 2020

Feb 08, 2021
BUY
$1.8 - $2.56 $348,008 - $494,945
193,338 Added 135.94%
335,558 $655,000
Q3 2020

Nov 06, 2020
BUY
$2.04 - $3.74 $119,193 - $218,520
58,428 Added 69.73%
142,220 $339,000
Q2 2020

Aug 05, 2020
BUY
$2.42 - $3.29 $202,776 - $275,675
83,792 New
83,792 $246,000

Others Institutions Holding ADMA

# of Institutions
346
Shares Held
181M
Call Options Held
1.72M
Put Options Held
846K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.86B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email